Biochemical and molecular processes related to initiation and progression of the atherosclerotic lesion have yet to be fully defined. This SCOR program is an interdisciplinary approach to the study of thrombotic disease and angiogenesis as it relates to atherogenesis. How these processes relate at the cellular and molecular level will be a significant theme of the program. Our investigation will include a genetic engineering approach employing several animal models of the disease (mouse CD36 and apo E knockout models, rat angioplasty model, and the rabbit atherosclerosis model) to address: scavenger receptors in foam cell development, fibrinolytic factors and tissue-remodeling in angiogenesis, mitogenic factors in the formation of the coronary network and patterning of coronary vessels, and the molecular deficiencies associated with growth control of atherosclerotic cells using dominant-negative constructs to specific growth factor receptor genes. To address these objectives, a Molecular Biology/Gene Transfer Core has been constructed to facilitate investigations involving gene transfer, gene regulation, and maintenance of the genetically-modified animal models. In addition, a gene therapy approach will be used to develop clinical strategies for the induction of angiogenesis. Emphasis has also been placed on the use of clinical samples consisting of human atherosclerotic and restenotic tissues. These materials will be studies in an effort to extend the paradigms resulting from the use of genetically modified animal models to advance our understanding of human lesion progression. Our SCOR program has been crafted to capitalize on the complimentary research expertise of our cardiovascular biology group at Cornell. Together, our synergistic efforts have culminated in over 100 peer-reviewed, basic research papers in the past 5 years, underscoring the success of our scientific collaborations. As a testament to our achievements, Cornell Medical School has recently developed a new Center of Vascular Biology, headed by Dr. David Hajjar. Committed institutional funds (greater than $1.0 million) are earmarked for modern capital improvements to include renovations of laboratories, the purchase of new equipment, and for faculty recruitment.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL056987-05
Application #
6389415
Study Section
Special Emphasis Panel (ZHL1-CSR-K (F1))
Program Officer
Wassef, Momtaz K
Project Start
1997-04-23
Project End
2003-03-31
Budget Start
2001-04-01
Budget End
2003-03-31
Support Year
5
Fiscal Year
2001
Total Cost
$1,231,515
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Pathology
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Gagarin, Dmitry; Yang, Zhaoqing; Butler, Jason et al. (2005) Genomic profiling of acquired resistance to apoptosis in cells derived from human atherosclerotic lesions: potential role of STATs, cyclinD1, BAD, and Bcl-XL. J Mol Cell Cardiol 39:453-65
Hyer, Jeanette; Kuhlman, Julie; Afif, Evelyn et al. (2003) Optic cup morphogenesis requires pre-lens ectoderm but not lens differentiation. Dev Biol 259:351-63
Kelly, Kristine A; Wei, Yan; Mikawa, Takashi (2002) Cell death along the embryo midline regulates left-right sidedness. Dev Dyn 224:238-44
Han, Jihong; Hajjar, David P; Zhou, Xiaoye et al. (2002) Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoprotein. J Biol Chem 277:23582-6
Takebayashi-Suzuki, K; Pauliks, L B; Eltsefon, Y et al. (2001) Purkinje fibers of the avian heart express a myogenic transcription factor program distinct from cardiac and skeletal muscle. Dev Biol 234:390-401
Han, J; Nicholson, A C; Zhou, X et al. (2001) Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I. J Biol Chem 276:16567-72
Feng, J; Han, J; Pearce, S F et al. (2000) Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res 41:688-96
Takebayashi-Suzuki, K; Yanagisawa, M; Gourdie, R G et al. (2000) In vivo induction of cardiac Purkinje fiber differentiation by coexpression of preproendothelin-1 and endothelin converting enzyme-1. Development 127:3523-32
Du, B; Fu, C; Kent, K C et al. (2000) Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor. J Biol Chem 275:39039-47
Febbraio, M; Podrez, E A; Smith, J D et al. (2000) Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 105:1049-56

Showing the most recent 10 out of 24 publications